Newsroom | 4386 results

SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health will present new clinical data from its ongoing PRESERVE I study at the 2026 Tandem Meetings on February 4-7, 2026 in Salt Lake City....

ROCHESTER, Minn.--(BUSINESS WIRE)--INTENT Biologics, a clinical-stage biotechnology company developing PEP Biologic as the first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the U.S. Food and Drug Administration (FDA) has agreed to INTENT’s Initial Pediatric Study Plan (iPSP) for PEP Biologic™ under IND 019567, supporting the company’s request for a full pediatric waiver for its forthcoming Biologics License Applicati...

DUBLIN--(BUSINESS WIRE)--The "Achromatopsia Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Achromatopsia Market is experiencing substantial growth, expected to increase from USD 121.99 million in 2026 to USD 191.22 million by 2032 at a compound annual growth rate of 7.58%. This comprehensive market research report provides valuable insights into the dynamic landscape of achromatopsia, driven by advances in genetic characterization, diagnostics, and...

MENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that new clinical data will be presented in two oral and seven poster sessions at the 2026 Tandem Meetings of ASTCT and CIBMTR from February 4-7 in Salt Lake City, UT. The presentations will include data on the company's pipeline of investigational allogeneic T-cell immunotherapies for the treatment of multiple hem...

OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd, a global leader in immunological reagents and services, announced the launch of Mastering Immunity 2026 – Shanghai, an inaugural symposium in China providing practical, real-world guidance to help drug developers manage immunogenicity risk. Taking place at the Oriental Riverside Hotel in Shanghai, the event will convene leading scientists, industry executives, and regulatory professionals from around the world. Immunogenicity, the potential for b...

FAIRFAX, Va.--(BUSINESS WIRE)--Vibrent Health, a leading software-as-a-service (SaaS) data company in the field of precision medicine research, is collaborating with Fred Hutch Cancer Center (Fred Hutch) under a $17 million contract awarded through the Biomedical Advanced Research and Development Authority’s (BARDA) Rapid Response Partnership Vehicle (RRPV) Consortium. This collaboration drives critical research on correlates of protection (CoPs), which are measurable immune markers predicting...

SEATTLE--(BUSINESS WIRE)--The Cord Blood Council (CBC), a new capacity building nonprofit, has launched to support the nation’s public cord blood banks. The organization develops and provides shared resources to National Cord Blood Inventory (NCBI)–funded, FDA licensed public cord blood banks and the clinicians, researchers, and patients who depend on them. The CBC was created to modernize and unify critical capabilities across the cord blood community. By coordinating expertise, infrastructure...

MENLO PARK, Calif.--(BUSINESS WIRE)--Emmecell announces the appointment of ophthalmology leader Ramin Valian as CEO....

DUBLIN--(BUSINESS WIRE)--The "Molecular Biology for the Non-molecular Biologist Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering. Elevate your expertise in molecular biology to excel in pharmaceuticals research, development and manufacturing. Molecular biology is not just a theoretical pursuit; it's a practical tool essential for understanding and manipulating the DNA, RNA and protein interactions that underpin drug discovery, development...

IRVINE, Calif.--(BUSINESS WIRE)--Immunis, a clinical-stage biotech company pioneering multi-active secretome-based biologics, today announced positive topline interim results from STEM-META, a double-blind placebo-controlled study of the IMM01-STEM secretome in overweight seniors experiencing muscle loss and metabolic dysfunction. In recognition of the news, Immunis Chairman, Dr. Hans Keirstead, will be speaking at Biotech Showcase on a panel about cutting-edge immune-based therapeutics. The st...